Neurocrine Biosciences, Inc. (Nasdaq: NBIX) is lower after-hours Tuesday after the company announced an offering to sell 7,000,000 shares of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE